EyeControl

Wearable Assistive Communication Device

Health Tech & Life Sciences
Active
Series A Bnei Brak, Israel Founded 2016
Last updated 2026-06-18
Total raised
$15.2M
Last: 2025-04
Stage
Series A
Founded
2016
Headcount
22
HQ
Bnei Brak, Israel
Sector
Health Tech & Life Sciences

About

EyeControl is a medical technology company revolutionizing ICU care with its AI-powered eye-tracking platform. Designed to empower mechanically ventilated patients, it enables effective communication, connects families and caregivers, and provides healthcare teams with actionable insights. By supporting implementation of evidence-based practices for optimizing critical care, EyeControl enhances patient safety, improves cognitive and mental health outcomes, and fosters meaningful connections.

The EyeControl device is FDA-listed, CE-marked, ISO-certified, and AMAR and MAKAT registered as a communication solution. It is federally reimbursed in Israel for inpatient settings and homecare.

Funding history · 14 rounds · $15.2M total

2025-04
Undisclosed
2024-05
Grant Undisclosed
2024-01
Grant Undisclosed
2023-01
Grant Undisclosed
2022-01
Grant Undisclosed
2020-08
Grant $2.5M
2019-10
Grant $750K
2017-11
Grant $2.0M
2017-10
Undisclosed
2016-07
Grant $5K
2016-07
2015-08
$50K

Q&A

What is EyeControl's primary business?
EyeControl is a medical technology company that develops an AI-powered eye-tracking platform for mechanically ventilated patients, enabling communication and providing insights for healthcare teams.
When was EyeControl founded?
EyeControl was founded in January 2016.
Where is EyeControl headquartered?
EyeControl is headquartered in Bnei Brak, Center District, Israel.
How many employees does EyeControl have?
EyeControl has 11-50 employees.
What is the total amount of funding EyeControl has raised to date?
EyeControl has raised a total of $15,213,000.
When did EyeControl last raise funding?
EyeControl's most recent funding round occurred in April 2025, with ExitValley participating.
Which investors participated in EyeControl's August 2020 funding round?
In August 2020, Connecticut Innovations led a funding round for EyeControl, with participation from.
What is the regulatory status of the EyeControl device?
The EyeControl device is FDA-listed, CE-marked, ISO-certified, and AMAR and MAKAT registered as a communication solution. It is also federally reimbursed in Israel for inpatient settings and homecare.
Who are the co-founders of EyeControl?
The co-founders of EyeControl are Or Retzkin, Itai Kornberg, Izhack Davidovich, and Shay Rishoni.

Team · 4

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Founder & CEO, YD-Investments
LinkedIn ↗
Founder · Co-founder & CTO
LinkedIn ↗
Founder · Co-founder (late)
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesAssistive DevicesDigital HealthcareDigital Accessibility Solutions
Technologies
Platforms & InterfacesSoftwareMobileArtificial IntelligenceMachine LearningComputer VisionCommunications
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2CB2BB2B2C

Highlights

1 PatentsVerified

Tags

mental-healthhome-caredegenerative-diseasesneurologymhealthcomputer-visiondigital-healthcaremobile-applicationspatientseye-trackinghospitalsamyotrophic-lateral-sclerosis-alsartificial-intelligencenon-invasivewearabledisabilitiesassistive-devicesventilationmultiple-sclerosiswireless-communicationstrokemedical-devicesmachine-learningmedical-technologiescommunicationsnatural-language-processingwearable
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)